Jassie,
"Gewoon standaard rapportjes die niets van doen hebben met de potentie van het bedrijf."
Waar gaan die rapportjes dan over, waar vullen ze dan al die bladzijdes mee, met plaatjes van geitjes misschien ?
15-Jun-05
Contributor: EconomicInvestor
Title: "The Economy Matters" Report: evaluates how favorable the current U.S. economic climate is for GTCB; analyzes economic impact on stock value and riskiness; includes industry segment comparisons. (5/19/05 report with MacroRisk Factor update)
Document Size: 18 pages
Date: 14-Jun-05
Contributor: TrueCourse, Inc.
Title: SharkRepellent.net Takeover Defense Profile: GTC Biotherapeutics, Inc.
Document Size: 5 pages
Price: $80
Date: 14-Jun-05
Author: Alfred Mansour Ph.D.
Contributor: BiotechWatch LLC
Title: BiotechWatch's profile of GTC Biotherapeutics tracks products in clinical development, cash on hand, clinical trial status, milestones, corporate alliances, and current stock prices and fundamentals
Document Size: 52 pages
Price: $100